Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow ENDRA Life Sciences Inc.

Get SEC filing alerts via email and in your feed for ENDRA Life Sciences Inc.

NDRA

ENDRA Life Sciences Inc.

About ENDRA Life Sciences Inc.

ENDRA Life Sciences develops advanced ultrasound-based platforms, primarily TAEUS, for non-invasive detection and monitoring of liver fat and metabolic diseases. Its core focus is on creating scalable, cost-effective diagnostic tools leveraging thermoacoustic technology, AI integration, and existing ultrasound systems. Serving pharmaceutical, clinical, and medical markets globally, the company aims to improve early diagnosis, disease management, and therapeutic monitoring for conditions like fatty liver disease and obesity.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from ENDRA Life Sciences Inc.

1
1
ENDRA Life Sciences Inc. ENDRA Life Sciences Reports Increased Net Loss and Rising Operating Expenses in Q1 2026

Via official filing (AI summary) | 19 days ago | 0 comments

2
1
ENDRA Life Sciences Inc. ENDRA Life Sciences Reports $7.03 Million Net Loss for Fiscal Year 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
ENDRA Life Sciences Inc. ENDRA Life Sciences Reports Q3 2025 Financial Results with Reduced Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
ENDRA Life Sciences Inc. ENDRA Life Sciences Reports No Revenue and Reduced Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
ENDRA Life Sciences Inc. ENDRA Life Sciences Reports Q1 2025 Financial Results with Reduced Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
ENDRA Life Sciences Inc. ENDRA Life Sciences Reports $11.5 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
ENDRA Life Sciences Inc. ENDRA Life Sciences Reports Improved Financial Results, Reduced Operating Expenses, and Enhanced Cash Reserves

Via official filing (AI summary) | over 1 year ago | 0 comments